(Q35086797)

6 August 2017

1 reference

title

Statin therapy in the elderly: does it make good clinical and economic sense? (English)

1 reference

6 August 2017

1 reference

Moira M B Mungall

1

1 reference

6 August 2017

Allan Gaw

series ordinal

2

1 reference

6 August 2017

James Shepherd

series ordinal

3

1 reference

6 August 2017

language of work or name

1 reference

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

20

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

263-275

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200320040-00003

6 August 2017

exact match

0 references

cites work

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Issues surrounding age: vascular disease in the elderly

1 reference

12 December 2020

Role of lipids in osteoporosis

1 reference

12 December 2020

Cholesterol and mortality. 30 years of follow-up from the Framingham study

1 reference

12 December 2020

HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients

1 reference

12 December 2020

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

12 December 2020

Statins and the risk of dementia

1 reference

12 December 2020

Should there be a moratorium on the use of cholesterol lowering drugs?

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors

1 reference

12 December 2020

Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease

1 reference

12 December 2020

Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Overview of atherosclerosis.

1 reference

12 December 2020

Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Underestimation of the importance of blood pressure and cholesterol for coronary heart disease mortality in old age.

1 reference

12 December 2020

Serum C-reactive protein and self-reported stroke: findings from the Third National Health and Nutrition Examination Survey

1 reference

12 December 2020

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

1 reference

12 December 2020

Epidemiology of coronary heart disease: the Framingham study.

1 reference

12 December 2020

Mortality by cause for eight regions of the world: Global Burden of Disease Study

1 reference

12 December 2020

Effect of statins on C-reactive protein in patients with coronary artery disease

1 reference

12 December 2020

Age influence on the immune system

1 reference

12 December 2020

Effect of pravastatin treatment on glucose, insulin, and lipoprotein metabolism in patients with hypercholesterolemia.

1 reference

12 December 2020

Effects of pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, on glucose tolerance in patients with essential hypertension

1 reference

12 December 2020

C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons

1 reference

12 December 2020

Serum cholesterol concentrations and all-cause mortality in older people

1 reference

12 December 2020

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study

1 reference

12 December 2020

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

1 reference

12 December 2020

The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis.

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Dietary vitamin E and T cell-mediated function in the elderly: effectiveness and mechanism of action.

1 reference

12 December 2020

Serum cholesterol, high-density lipoprotein cholesterol and five-year survival in elderly people

1 reference

12 December 2020

Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population

1 reference

12 December 2020

Serum cholesterol and 20-year mortality in black and white men and women aged 65 and older in the Evans County Heart Study

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients

1 reference

12 December 2020

Is hypercholesterolemia a risk factor and should it be treated in the elderly?

1 reference

12 December 2020

Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study

1 reference

12 December 2020

Aging and immune function

1 reference

12 December 2020

Stimulation of bone formation in vitro and in rodents by statins

1 reference

12 December 2020

Elderly patients at risk for coronary heart disease or stroke: selecting an ideal product for lipid lowering

1 reference

12 December 2020

Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Health promotion and the compression of morbidity

1 reference

12 December 2020

Economics of drug treatment: for which patients is it costeffective to lower cholesterol?

1 reference

12 December 2020

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

12 December 2020

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

1 reference

12 December 2020

C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly

1 reference

12 December 2020

Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years

1 reference

12 December 2020

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

1 reference

12 December 2020

Inhibition of proinflammatory cytokine production by pravastatin

1 reference

12 December 2020

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

1 reference

12 December 2020

The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

1 reference

12 December 2020

Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering

1 reference

12 December 2020

Indications for cholesterol-lowering medication: comparison of risk-assessment methods

1 reference

12 December 2020

Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)

1 reference

12 December 2020

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

12 December 2020

The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients

1 reference

12 December 2020

International economic analysis of primary prevention of cardiovascular disease with pravastatin in WOSCOPS. West of Scotland Coronary Prevention Study.

1 reference

12 December 2020

Diminished calcium signal generation in subsets of T lymphocytes that predominate in old mice.

1 reference

12 December 2020

Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Age-associated changes in human T cell phenotype and function.

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

12 December 2020

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

12 December 2020

Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarction

1 reference

12 December 2020

SERUM LIPID LEVELS AND THE SEVERITY OF CORONARY AND CEREBRAL ATHEROSCLEROSIS IN ADEQUATELY NOURISHED MEN, 60 TO 69 YEARS OF AGE

1 reference

12 December 2020

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

1 reference

12 December 2020

The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin.

1 reference

12 December 2020

Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.

1 reference

12 December 2020

Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain

1 reference

12 December 2020

Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators.

1 reference

12 December 2020

10.2165/00002512-200320040-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

6 August 2017

1023801765

0 references

1 reference